SENSEX
NIFTY
GOLD
USD/INR

Weather

image 29    C

Economy News

The Economic Times

Economy / The Economic Times

details

Japan's Takeda bets on dengue vax to reshape India playbook

Takeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027. It will initially be available through the private market for individuals. Takeda plans to pursue government procurement and National Immunisation Programme inclusion. This move significantly broadens Takeda's public health focus in India.

5 Aug 2026 12:48 am